Husband & Wife Entrepreneurs, Nick Desai and Dr. Renee Dua, Inspired by their Own Children…
AUSTIN, Texas–(BUSINESS WIRE)–Workrise, the leading workforce and vendor management platform serving the energy sector, has…
Connectivity Bolsters Crypto Trading with TNS Network Access and Stability RESTON, Va.–(BUSINESS WIRE)–Transaction Network Services…
Award winners are recognized for achieving exceptional web impact SAN FRANCISCO–(BUSINESS WIRE)–#BestInWebOps—Pantheon, the SaaS-based website…
Primed to revolutionize quality management and compliance for the life sciences industry, Dot Compliance’s ready-to-use…
Over 90% of the shares voted to date have shown support “FOR” each of the…
Over 90% of the shares voted to date have shown support “FOR” each of the…
FLORHAM PARK, N.J., April 04, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
FLORHAM PARK, N.J., April 04, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Tel Aviv, Israel / Vancouver, Canada, April 04, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Tel Aviv, Israel / Vancouver, Canada, April 04, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Preliminary data of Ampligen seen to date demonstrates potential to be an effective treatment option…
Preliminary data of Ampligen seen to date demonstrates potential to be an effective treatment option…
MALVERN, Pa., April 04, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
MALVERN, Pa., April 04, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Clinical Trial Focuses on Assessing Whether LB-100 Enhances the Effectiveness of a Standard Regimen Combining…
Clinical Trial Focuses on Assessing Whether LB-100 Enhances the Effectiveness of a Standard Regimen Combining…
Roll-Out Across National Bioskills Training Centers Gives Med Device Companies and Surgeons Access to Intelligent…
Roll-Out Across National Bioskills Training Centers Gives Med Device Companies and Surgeons Access to Intelligent…
BOSTON, April 04, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…